Chinese Bioventures Grab $860m In Latest Public Listing, Financing Dash

Accelerated initial public listings, multi-million dollar deals and hot investment fund influxes fuel an already record-setting July for biotech fundraising in China.

fund raising
Chinese bioventures continue to scoop up funds • Source: Alamy

More from China

More from Focus On Asia